Top

Reactions Weekly

Published in:

01-02-2023 | Metabolic Acidosis | Case report

Nirmatrelvir+ritonavir/verapamil interaction

Various toxicities and off label use: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon; Drug interaction

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Haque OI, et al. Pharmacokinetic interaction between verapamil and ritonavir-boosted nirmatrelvir: implications for the management of COVID-19 in patients with hypertension. BMJ Case Reports 16: No. 1, Jan 2023. Available from: URL: http://doi.org/10.1136/bcr-2022-252677 [Summarised from an abstract]

Title: Nirmatrelvir+ritonavir/verapamil interaction
Various toxicities and off label use: case report
Publication date: 01-02-2023
Publisher: Springer International Publishing
Keywords: Metabolic Acidosis
Ritonavir
SARS-CoV-2
Verapamil
Hyperglycemia
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-33428-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Nirmatrelvir+ritonavir/verapamil interaction

Various toxicities and off label use: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Vancomycin

Antibacterials/amphotericin-B

Clopidogrel

Antineoplastics

Diphenhydramine overdose

Multiple drugs